Ovarian Cancer: Modern Treatment
In ovarian cancer, an illness that returns within six months of employment following platinum-based treatment is described as platinum-sensitive. A patient’s platinum-sensitivity status can vary…
In ovarian cancer, an illness that returns within six months of employment following platinum-based treatment is described as platinum-sensitive. A patient’s platinum-sensitivity status can vary…
Visits to principal care physicians have been befalling for decades in the U.S., and rising out-of-pocket costs are the main, although not the only, cause…
A Ludwig Cancer Research research has devised a different type of chimeric antigen receptor (CAR) T cell—a family of promising immunotherapies for cancer—that might be…
A new drug application (NDA) has been registered for expedited approval with the FDA for lurbinectedin in sufferers with small-cell lung cancer (SCLC) who have…
This is a crucial time in the field of gene treatment as the FDA (Food And Drug Administration) maintains its attempts to encourage innovators emerging…
The investigators in Canada discovered that a treat-and-extend (T&E) regimen of administering ranibizumab to sufferers with neovascular age-related macular illness produced similar results to monthly…
More than 2.8 million antibiotic-resistant infections occur in the United States each year, with approximately 35,000 Americans dying of these diseases yearly, according to CDC’s…
One of the essential changes in the science landscape for 2020 lies within the shift from the standard fee-for-service model to a value-based care payment…
In a retrospective series on sufferers with HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) who were handled with immune checkpoint inhibitors (ICI),…
The investigation was led by biomedical specialists at the University of California, Riverside has discovered that a medication recommended by the FDA (Food And Drug…